Morphosys Ag ADR (MOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | |
| Cash Flows From Operating Activities | |
| Net Income | -78,920 |
| Depreciation Amortization | 4,550 |
| Other Working Capital | 34,640 |
| Other Operating Activity | -3,720 |
| Operating Cash Flow | $-43,450 |
| Cash Flows From Investing Activities | |
| PPE Investments | -1,480 |
| Other Investing Activity | 38,700 |
| Investing Cash Flow | $37,220 |
| Cash Flows From Financing Activities | |
| Other Financing Activity | 9,230 |
| Financing Cash Flow | $9,230 |
| Beginning Cash Position | 83,560 |
| End Cash Position | 86,560 |
| Net Cash Flow | $3,000 |
| Free Cash Flow | |
| Operating Cash Flow | -43,450 |
| Free Cash Flow | -43,450 |